Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:39 AM UTC
| NCT Number | NCT05248230 |
| Recruiting Status | Recruiting |
| Condition | Cystic Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 20 sites in the US |
| Sponsor | 4D Molecular Therapeutics |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of August 31, 2026: Clinical trial NCT05248230 is currently recruiting participants. This phase2 study for cystic fibrosis is actively seeking new participants at 20 locations across the United States. The study is sponsored by 4D Molecular Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05248230 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05248230 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.